Pivot
Pivot

Joe Rogan’s Trump Jabs, Blockbuster Tech Earnings, and Another Tariff Deadline

Kara and Scott discuss the advancement of a bill to ban stock trading by lawmakers, President Trump’s Joe Rogan problem, and Ghislaine Maxwell agreeing to testify for immunity. Then, President Trump says he will not extend the latest August 1st tariff deadline, and Microsoft and Meta’s mega earnings

Featured Speakers

NY Mag Host

Topics Discussed

Episode Summary

Executive Summary: Pivot covers a Manhattan office-building mass shooting, congressional stock-trading reform, Joe Rogan’s growing criticism of Trump, tariff turmoil, blockbuster Microsoft and Meta AI earnings, Novo Nordisk’s GLP-1 setback, and a strong prediction that design platform Figma will be the IPO standout. The hosts argue that guns, corruption, and policy chaos are reinforcing U.S. instability while AI and GLP-1s remain major structural growth stories.

Main Topics: Manhattan mass shooting and gun policy (Priority: 5/5): The hosts discuss the shooting at an NFL-adjacent Manhattan office building, the suspected role of CTE, the broader prevalence of mass shootings, and why U.S. gun laws and access to assault weapons are central to the problem. Congressional stock trading and political corruption (Priority: 5/5): A Senate bill to ban stock trading by lawmakers is examined as largely performative but important for restoring trust, with a strong case for blind trusts, higher pay, and stricter ethics rules. Joe Rogan’s break with Trump (Priority: 4/5): Rogan’s criticism of immigration raids, deportations, student crackdowns, and the Epstein handling is treated as significant because of his influence on young men and the manosphere. Tariffs, the Fed, and market distortions (Priority: 5/5): The hosts argue Trump’s tariffs are vaporware-like frameworks that raise costs, distort trade, reduce competitiveness, and add uncertainty while Powell is right to hold rates steady. Microsoft and Meta’s AI-fueled earnings (Priority: 5/5): Both companies post huge quarters, reinforcing the view that the market is rewarding massive AI capex and concentrating capital in a small number of tech giants. Novo Nordisk and the GLP-1 market shakeout (Priority: 4/5): Novo Nordisk’s stock plunge is framed as an overreaction to competition, compounded by compounding/knockoff GLP-1s and execution issues, even as the category is judged highly valuable. Prediction: Figma as the IPO of the year (Priority: 4/5): Scott predicts Figma will be the breakout IPO, citing strong growth, profitability, design’s importance in the AI era, and the benefits of antitrust enforcement that blocked Adobe’s acquisition.

Key Arguments: CTE may be relevant in some football-related violence, but the larger driver of U.S. mass shootings is widespread access to weapons of war. Mass shootings have become normalized in the U.S.; people adapt to an intolerable reality instead of changing it. U.S. gun laws are undermined by interstate gun access, so state-level restrictions cannot fully protect residents. Congressional stock trading corrodes trust in markets; blind trusts and much higher compensation would reduce temptation and restore fairness. Trump’s tariff policy is economically destructive because tariffs raise consumer prices, reduce competition, and create uncertainty that depresses investment. The administration’s trade announcements are mostly nonbinding frameworks with unenforceable headline investment numbers. Microsoft and Meta are winning because the market believes in massive AI capital expenditures, and both companies are using AI to strengthen core businesses. The AI race is increasingly an infrastructure/capex war, concentrating even more market value in a few firms. Novo Nordisk’s GLP-1 leadership is being challenged by Eli Lilly and compounded knockoffs, but the broader GLP-1 category remains a major healthcare opportunity. Figma is attractive because design remains a durable human-led layer on top of AI, and the company has elite growth and efficiency metrics.

Data Points: People killed in Manhattan shooting: 4 - Office building shooting near NFL headquarters People injured in Manhattan shooting: 1 - Office building shooting near NFL headquarters Former NFL players studied with CTE: 376 players studied; 91% had CTE - Scott cited a study of former NFL players Lawmakers’ average salary mentioned: $174,000 - Current pay for Congress discussed as insufficient relative to living costs and corruption risk Pelosi family net worth: $420 million - Used as an example in the stock-trading ethics discussion Pelosi net worth increase last year: 54% - Used to argue that small corruption can signal bigger corruption Democratic and Republican stock returns mentioned: 31% for Democrats; 26% for Republicans - Cited in discussion of political stock trading Trump tariff on India: 25% - Announced tariff with penalty tied to Russian energy and military equipment Fed rate decisions: Held steady for the 5th meeting in a row - Used to support Powell’s wait-and-see approach Microsoft revenue: $76 billion - Quarterly revenue reported Microsoft revenue growth: 18% year over year - Strong cloud and AI-related performance Microsoft capital spending growth: 27% - Capex climbing as AI investment accelerates Meta revenue: $47 billion - Quarterly revenue reported Meta revenue growth: 22% - Strong ad business aided by AI Meta profit: $18 billion - Quarterly profit Meta profit growth: 36% - Year-over-year increase Meta technical talent compensation: Second-largest driver of cost growth - AI hiring spree affecting expenses AI spending vs consumer spending: More spending on AI than consumer spending last quarter - Used to illustrate scale of the AI investment boom Oracle ownership change by Larry Ellison: About 24% to closer to 41% - Illustration of how buybacks and capex changed ownership economics Novo Nordisk stock drop: 30% at one point - After slashing full-year guidance Novo Nordisk market value wiped out: Nearly $93 billion - Following weaker U.S. growth for Ozempic/Wegovy GLP-1 usage in the U.S.: 8% of Americans have taken one - Used to show category still has room to grow Americans interested in GLP-1s: About one-third - Indicates large future demand potential Obesity-related healthcare costs: $1.5 trillion per year - Used to argue GLP-1 access could lower system costs Figma growth rate: 44% - Part of the rule-of-40 calculation Figma profit margins: 20% - Part of the rule-of-40 calculation Figma rule of 40: 64 - Positions the company among top SaaS performers Figma over-subscription: 40x oversubscribed - Signal of strong IPO demand

Pivotal Quotes: "What we have a monopoly on is that all of these people have access to weapons of war." — Scott Galloway: Argument that guns, not just mental illness or head injuries, drive mass shootings "They are all frameworks that they can put out a press release." — Scott Galloway: Critique of Trump’s tariff “deals” as unenforceable PR rather than real policy "This vision is different from others in the industry who want to direct AI at automating all of the valuable work." — Mark Zuckerberg: Zuckerberg’s AI manifesto describing Meta’s personal superintelligence pitch

Implications: The episode argues that U.S. politics and markets are being shaped by avoidable dysfunction—guns, corruption, tariffs, and performative leadership—while real opportunity is concentrated in AI, GLP-1s, and design software. For listeners, the lesson is to watch structural winners, not headlines.

🔓 Sign Up for Unlimited Episode Search

About Pivot

With great power, comes great scrutiny. Every Tuesday and Friday, journalist Kara Swisher and NYU Professor Scott Galloway offer sharp, unfiltered insights into the biggest stories in tech, business, and politics. They make bold predictions, pick winners and losers, and bicker and banter like no one else. From New York Magazine and the Vox Media Podcast Network.

View all episodes from Pivot